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A Semiparametric Joint Model for Terminal Trend of Quality of Life and Survival in 
Palliative Care Research 
ABSTRACT 
Palliative medicine is an interdisciplinary specialty focusing on improving quality of life (QOL) 
for patients with serious illness and their families. Palliative care programs are available or under 
development at over 80% of large US hospitals (300+ beds). Palliative care clinical trials present 
unique analytic challenges relative to evaluating the palliative care treatment efficacy which is to 
improve patients’ diminishing QOL as disease progresses towards end of life (EOL). A unique 
feature of palliative care clinical trials is that patients will experience decreasing QOL during the 
trial despite potentially beneficial treatment. Often longitudinal QOL and survival data are highly 
correlated which, in the face of censoring, makes it challenging to properly analyze and interpret 
longitudinal QOL trajectory. To address these issues, we propose a novel semiparametric statistical 
approach to jointly model longitudinal QOL and survival data. There are two sub-models in our 
approach: a semiparametric mixed effects model for longitudinal QOL and a Cox model for 
survival. We use regression splines method to estimate the nonparametric curves and AIC to select 
knots. We assess the model through simulation and application to establish a novel modeling 
approach that could be applied in future palliative care treatment research trials.   
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1. INTRODUCTION 
Palliative care is a relatively new interdisciplinary specialty (medicine, nursing, social work, 
chaplaincy, and other specialties when appropriate) that focuses on improving quality of life for 
patients of any age with any serious disease , whether  it  can  be  cured  or controlled, and for their 
families (Kelley and Morrison 2015). Data from 2010 have shown that palliative care programs 
were available or under development at more than 80% of large US hospitals (300+ beds) (Kelley 
and Meier 2010). Understanding of terminal trends or trajectories of QOL through carefully 
designed palliative care studies is crucial to help practitioners, patients and their care givers gain 
a better understanding of ill trajectories which may then help them feel in better control and 
empower them to cope with difficulties (Murray et al. 2005). Palliative care clinical trials present 
unique analytic challenges relative to evaluating the palliative care treatment efficacy in terms of 
improving patients’ diminishing QOL as disease progresses towards EOL. QOL, symptom burden, 
anxiety, depression, and resource use, rather than survival, are common endpoints chosen to 
evaluate treatment efficacy of palliative care (Bakitas et al. 2009, Temel et al. 2010, Bakitas et al. 
2015). These measures are captured longitudinally over relatively short time frames as patients’ 
prognosis, especially in cancer palliative care trials, averages about a year. Additionally some 
patients may drop out or live beyond study end, resulting in longitudinal data and death times being 
censored. When analyzing palliative care studies, the interplay between longitudinal QOL and 
survival outcomes should be taken into account because these two outcomes typically strongly 
related, especially during EOL period, such that shortened survival and worsening QOL and 
symptoms are highly correlated. Without appropriate modeling of the correlation, estimates could 
be inefficient and potentially biased, and the clinical interpretation could be distorted. Censoring 
of the survival times occurs frequently due to dropout or study end, making it challenging to 
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account for the correlation. To have the most accurate assessment of treatment efficacy (clinical 
effect) and avoid distorted interpretations and inefficient analyses due to censoring, it is important 
to thoughtfully consider survival-longitudinal data correlation in data analysis. To address these 
issues, we propose a novel statistical approach for jointly modeling longitudinal and survival data 
in palliative care trials.    
In the statistical literature, significant effort has been devoted to methods for jointly modeling 
longitudinal and time-to-event data. Due to the complex nature of the joint distribution of 
longitudinal measurements 𝑌  and time-to-event outcome 𝐷 , two sub-models are commonly 
employed for the two types of outcomes, and these sub-models account for their dependency 
through conditional distribution or shared (or correlated) random effects. Comprehensive reviews 
on the differences and connections of these approaches can be found in the literature (Hogan and 
Laird 1997b, Tsiatis and Davidian 2004, Kurland et al. 2009, Rizopoulos and Lesaffre 2014) . One 
common approach, called shared parameter models, construct models for the two marginal 
distributions 𝑓(𝑌) and 𝑓(𝐷) rather than factoring the joint distribution and accounting for the 
dependence between 𝑌 and 𝐷 using shared or correlated random effects (Wulfsohn and Tsiatis 
1997, Henderson, Diggle, and Dobson 2000, Elashoff, Li, and Li 2007, Liu, Wolfe, and 
Kalbfleisch 2007, Li et al. 2010, Barrett et al. 2015). Another general model, pattern-mixture 
models (Wu and Bailey 1989, Hogan and Laird 1997a, Fitzmaurice and Laird 2000, Su and Hogan 
2010), factors the joint distribution 𝑓(𝑌, 𝐷) into 𝑓(𝑌|𝐷)𝑓(𝐷) and models 𝑓(𝑌|𝐷) and 𝑓(𝐷) with 
two sub-models, where the sub-model for 𝑓(𝑌|𝐷) is usually modeled by a multivariate normal 
distribution conditional on the death time and hence the marginal distribution of 𝑌 is a mixture of 
normal distributions over the survival distribution. In these approaches, the trajectories of 
longitudinal outcomes are usually assumed to have different patterns given different death or 
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dropout times. A third general approach, the selection model (Diggle and Kenward 1994),  factors 
the joint distribution in an opposite way by writing the joint distribution as 𝑓(𝐷|𝑌)𝑓(𝑌), where 
the primary endpoint is usually survival. For longitudinal data prior to death, Kurland and Heagerty 
(2005) proposed a “partly conditional” approach that models the longitudinal outcomes conditional 
on the subjects being alive using weighted GEE where the survival data does not have to be 
explicitly modeled.  
Another approach for longitudinal data prior to death, which we refer to as terminal trend 
model in this paper, is to jointly model the terminal trend of longitudinal data and survival by 
looking at the longitudinal data on the retrospective time scale from death time. Kurland et al. 
(2009) described a terminal trend model for analyzing only the decedents whose death times are 
observed. Unfortunately, the decedent analysis can generate substantial efficiency loss by omitting 
censored subjects when censoring rate is high (e.g., 47.34% for the motivating example described 
in Section 2). A decedent analysis could also generate biased results if the subgroup of decedents 
involves selection bias (Bach, Schrag, and Begg 2004). To alleviate the loss of power due to 
removing the censored subjects entirely, Li et al. (2013) developed a parametric terminal trend 
model specifically for cancer palliative care studies by appropriately accounting for censoring and 
this method has been applied in Bakitas (2015). In a related method designed for analyzing 
longitudinal cost data, Liu et al. (2007) proposed a ‘turn back time’ method for censored 
observations to characterize costs on a retrospective time scale which re-censors the longitudinal 
outcomes at some fixed time before the actual censoring time, while keeping the actual censoring 
time for the survival data.  
The prominent advantage of a terminal trend model is that it directly estimates the terminal 
trend until death by modeling the longitudinal data on a retrospective time scale. Understanding 
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the terminal trend is extremely important to help clinicians plan care to meet their patient’s 
multidimensional needs better, and help patients and care givers cope with their situation (Murray 
et al. 2005). Therefore, terminal trend models are of particular interest for palliative care studies. 
The terminal trend model developed in Li et al. (2013) was a fully parametric model specifically 
proposed for studies with cancer patients. In this paper, we will develop a semiparametric terminal 
trend model with a semiparametric mixed effects sub-model for the longitudinal QOL outcomes 
and a Cox sub-model for the survival outcome. Use of nonparametric functions for the longitudinal 
trajectories allows us to build a much more flexible model that is not subjective to model 
misspecification and thus makes the model applicable to other disease populations as well (e.g., 
heart failure, dementia). Regression spline methods with natural cubic B-splines will be employed 
to estimate the unspecified nonparametric terminal trend. Quality-adjusted life years (QALY) can 
be also derived and analyzed using this terminal trend model.  
The rest of this paper is organized as follows. Section 2 introduces the palliative care 
ENABLE III (Educate, Nurture, Advise, Before Life Ends, III) randomized clinical trial (RCT) 
that motivated this development. Section 3.1 gives notation and specifies the proposed statistical 
models. Estimation of the model parameters is detailed Section 3.2. The procedure for selecting 
the knots is described in Section 3.3. Estimation of QALY is presented in Section 3.4. A simulation 
study is described in Section 4. Application of the model to the ENABLE III RCT is provided in 
Section 5, followed by a discussion in Section 6. 
2. MOTIVATING EXAMPLE 
ENABLE III (Bakitas et al. 2015) was a two-arm palliative care RCT (conducted between 
October, 2009 and March, 2013) investigating the benefits of palliative care introduced soon after 
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diagnosis (early group) compared with 12 weeks after randomization (delayed group) for patients 
with advanced cancer. Two hundred and seven patients were randomly allocated to either the early 
group (𝑛 = 104) or the delayed group (𝑛 = 103). QOL data assessed by the 46-item Functional 
Assessment of Chronic Illness Therapy-Palliative Care (FACIT-pal) were collected at baseline and 
at 6, 12, 18, and 24 weeks and every 12 weeks thereafter until death or study completion.  
 
Figure 1. Mean QOL and the 95% confidence intervals (CI) for the first 10 follow up 
measurements where 0 denotes baseline. 
Higher FACIT-pal scores indicate better QOL. Clinically, QOL is expected to decrease as a patient 
approaches death (Murray et al. 2005). However, in ENABLE III the overall pattern of observed 
mean QOL increased overtime (Figure 1). This paradoxical phenomenon can be explained by the 
survival distribution and the QOL terminal trend because patients who were very ill, and 
presumably a lower QOL, died sooner. Thus the mean QOL increased as the surviving patients 
were on average less ill. In ENABLE III, the hazard rate was higher in the first 12-month time 
period (results shown in Section 5), which is consistent with this explanation. When comparing 
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QOL between the two arms in a study such as ENABLE III, it is important to adjust for any survival 
differences because better QOL in the early treatment group could simply be due to patients’ longer 
survival. Therefore, joint modeling of the terminal decline of QOL and survival data is essential 
to more accurately interpret the study’s results. 
3. METHOD 
3.1 Notation and Model 
Suppose there are 𝑁  patients in a study. Let 𝐷𝑖  denote the death time of the ith subject 
calculated as the duration from the date of enrollment to the date of death. Let 𝑌𝑖(𝑡
∗) denote the 
outcome, e.g. QOL, measured at time 𝑡∗ counting backward from the time of death for the 𝑖th 
patient. So the time 𝑡∗ is on a retrospective time scale starting from the death time. Let 𝐴𝑖 denote 
the binary treatment status with value of 1 being treatment and value of 0 being control for the ith 
patient, 𝑖 = 1, … , 𝑁. A time-varying treatment effect model for the mean trajectory of 𝑌𝑖(𝑡
∗) is 
given by 
𝐸[𝑌𝑖(𝑡
∗)|𝐴𝑖] = 𝛽𝜇(𝑡
∗) + 𝐴𝑖𝛽𝐴(𝑡
∗), 
where 𝛽𝜇(𝑡
∗) denotes the mean trajectory in the control group and the 𝛽𝐴(𝑡
∗) denotes the time-
varying treatment effect at time 𝑡∗ counting backward from the time of death for the 𝑖th patient. 
Both 𝛽𝜇(𝑡
∗)  and 𝛽𝐴(𝑡
∗)  are unspecified smooth functions. Under a mixed effects model 
framework for the longitudinal measurements (Diggle et al. 2002), the model adjusting for 
covariates is given by 
 𝑌𝑖(𝑡
∗) = 𝛽𝜇(𝑡
∗) + 𝐴𝑖𝛽𝐴(𝑡
∗) + 𝑋𝑖
𝑇𝜓𝑋 + 𝑍𝑖
𝑇𝑏𝑖 + 𝜀𝑖(𝑡
∗),                                        (1) 
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where 𝜓𝑋  is the 𝑃-dimensional vector of fixed effect parameters associated with the covariate 
vector 𝑋𝑖  (the superscript 𝑇 denotes transpose of a vector or matrix) and 𝑏𝑖  are independent 𝐿-
dimensional vectors of random effects associated with the covariates 𝑍𝑖. In a randomized trial, no 
covariate adjustment is necessary for the standard intent-to-treat analysis, but is introduced here to 
cover observational studies as well. The random effects 𝑏𝑖 are assumed to follow a multivariate 
normal distribution 𝑁(0, Σ) where Σ is a 𝐿 by 𝐿 variance-covariance matrix. The residual error 
𝜀𝑖(𝑡
∗) is assumed to be normally distributed with mean 𝐸[𝜀𝑖(𝑡
∗)] = 0 and var[𝜀𝑖(𝑡
∗)]=𝜏2, where 
𝜀𝑖(𝑡
∗) and 𝜀𝑖(𝑠
∗) are independent for any 𝑡∗ ≠ 𝑠∗. The random effects 𝑏𝑖 and residual error 𝜀𝑖(𝑡
∗) 
are assumed independent as in Zhang et al. (1998).  
Notice that time points of the longitudinal measurements on the retrospective time scale are 
unknown for those subjects whose death times are censored. Therefore, the retrospective time 𝑡∗ is 
missing because 𝐷𝑖 is missing. To resolve this issue, we model the survival time with a Cox model 
(Cox 1972) so that all those censored subjects can be included in the analysis. The survival model 
is on a prospective time scale and can be written as:  
𝜆𝑖(𝑡) = 𝜆𝑜(𝑡) exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋),                                              (2) 
where 𝑡 denote the time from enrollment on the prospective time scale and 𝛼𝑋  denote the 𝑄-
dimensional parameters associated with the 𝑄-dimensional covariates ?̃?𝑖. The death time may be 
right censored by another event time denoted by 𝐶𝑖 (e.g., withdrawal or study end). We assume 
that the censoring is independent of the longitudinal outcome and independent of the death time 
conditional on the covariates, which is true if there is only administrative censoring. The censoring 
times 𝐶𝑖 are also assumed to be independent of the random effects and the residual in model (1).  
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Models (1) and (2) form the two sub-models of our joint modeling approach for longitudinal 
and survival outcomes. Regression splines will be used to handle the unspecified terminal trend as 
detailed in the next section.  
3.2 Estimation 
Regression splines approach is proposed to estimate unspecified parameter functions 𝛽𝜇(𝑡
∗) 
and 𝛽𝐴(𝑡
∗) in sub-model (1). Natural cubic splines with B-splines basis (Eilers and Marx 1996, de 
Boor 2000, Wu and Zhang 2006) will be used with the knots equally spaced at the sample quantiles 
of the data. The procedure for determining the optimal number of knots is outlined in the next 
section. For the purpose of illustration and simplicity, we assume that the natural cubic splines for 
𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) have the same 𝑘1 knots corresponding to 𝑘1 basis functions. The exact same 
logic can be followed when they have different knots. Once all the knots have been specified, the 
longitudinal model can be converted into parametric form. Let 𝐵𝑖
1, 𝑖 = 1, … , 𝑘1 denote the B-spline 
basis functions. Notice that the basis functions 𝐵𝑖
1  depend on 𝑡∗  and we suppressed 𝑡∗  in the 
notations for simplicity. By approximating the unspecified function with the basis functions: 
𝛽𝜇(𝑡
∗) = ∑ 𝛽𝑘𝐵𝑘
1𝑘1
𝑘=1  and 𝛽𝐴(𝑡
∗) = ∑ 𝛽𝑘+𝑘1
𝑘1
𝑘=1 𝐵𝑘
1, sub-model (1) can be rewritten as  
𝑌𝑖(𝑡
∗) = 𝒳𝑖(𝑡
∗)𝑇𝛽 + 𝑍𝑖
𝑇𝑏𝑖 + 𝜀𝑖(𝑡
∗)                                                  (3) 
where 𝒳𝑖(𝑡
∗)𝑇 = (𝐵1
1, … , 𝐵𝑘1
1 , 𝐴𝑖𝐵1
1, … , 𝐴𝑖𝐵𝑘1
1 , 𝑋𝑖
𝑇), a (2𝑘1 + 𝑃)-dimensional vector of variables 
and 𝛽 = (𝛽1, … , 𝛽𝑘1 , 𝛽𝑘1+1, … , 𝛽2𝑘1 , 𝜓𝑋)
𝑇 . Maximum likelihood estimates (MLEs) will be 
obtained by maximizing the joint log-likelihood function for all parameters denoted by 𝜃 =
(𝛼, 𝛽, Σ, τ, Λ0(𝑡))  where 𝛼 = (𝛼𝐴, 𝛼𝑋)  and the cumulative baseline hazard function Λ0(𝑡) =
∫ 𝜆𝑜(𝑠)𝑑𝑠
𝑡
0
. 
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Let 𝑌𝑖𝑗 denote the outcome measured at 𝑡𝑖𝑗
∗  for the 𝑖th subject, 𝑖 = 1, … , 𝑁; 𝑗 = 1, … , 𝑛𝑖. Keep 
in mind that the time scale counts backward, which implies that 𝑦𝑖1  is the first measurement 
counting backward from the death time. The outcome vector 𝑌𝑖 = (𝑌𝑖1, … , 𝑌𝑖𝑛𝑖)
𝑇 has a multivariate 
normal distribution 𝑁(𝜇𝑖, 𝑉𝑖) with the mean vector 𝜇𝑖 having the 𝑗th element equal to 𝒳𝑖(𝑡𝑖𝑗
∗ )𝑇𝛽 
and the variance matrix 𝑉𝑖 = 𝜏
2𝐼𝑛𝑖 + 𝑍𝑖Σ𝑍𝑖
𝑇, where 𝐼𝑛𝑖 is the 𝑛𝑖 by 𝑛𝑖 identity matrix. 
Since censoring is assumed to be independent of the longitudinal outcome and the death time 
conditional on the covariates, the censoring times can then be treated as constants rather than 
random in the formulation of the likelihood function. We divide the sample into four groups based 
on two factors: censored or not and with or without follow up longitudinal measurements. The first 
group consists of the patients who had at least one follow-up measurement before the death was 
observed in the study. So their contribution to the log-likelihood function comes from both the 
longitudinal measurements and the observed death times. Without loss of generality, let (𝑖 =
1, … , 𝑟1) denote patients in group 1. Their log-likelihood contribution is given by 
𝑙1 = −0.5 ∑ [𝑛𝑖 log(2𝜋) + log|𝑉𝑖| + (𝑌𝑖 − 𝜇𝑖)
𝑇𝑉𝑖
−1(𝑌𝑖 − 𝜇𝑖)]
𝑟1
𝑖=1 + ∑ [log(𝜆𝑜(𝐷𝑖)) +
𝑟1
𝑖=1
𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋 − exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ0(𝐷𝑖)].                                                              
The second group consists of those patients who had no longitudinal measurements before 
they died. Let (𝑖 = 𝑟1 + 1, … , 𝑟1 + 𝑟2)  denote the patients in group 2. Their log-likelihood 
contribution is given by the marginal likelihood of the observed survival times 𝑙2 =
∑ [log(𝜆𝑜(𝐷𝑖)) + 𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋 − exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ0(𝐷𝑖)]
𝑟1+𝑟2
𝑖=𝑟1+1
.                                                                    
The third group consists of those patients who had at least one follow-up measurement and 
their death times were censored. Let (𝑖 = 𝑟1 + 𝑟2 + 1, … , 𝑟1 + 𝑟2 + 𝑟3)  denote the patients in 
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group 3. Their contribution comes from the joint distribution of the longitudinal and survival data 
and the log-likelihood function is calculated as log of the integral of the conditional density of the 
longitudinal data over the survival distribution beyond the censoring time. It is given by 
𝑙3 = ∑ log (∫ 𝑓(𝑌𝑖|𝐷𝑖 = 𝑠) exp(𝐴𝑖𝛼𝐴
+∞
𝐶𝑖
𝑟1+𝑟2+𝑟3
𝑖=𝑟1+𝑟2+1
+ ?̃?𝑖
𝑇𝛼𝑋) exp[− exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ0(𝑠)] dΛ0(𝑠) ), 
where 𝑓(𝑌𝑖|𝐷𝑖 = 𝑠) is the conditional multivariate normal density function of the longitudinal 
outcome given death time is 𝑠 . The joint likelihood function can be viewed as a weighted 
likelihood function of the longitudinal data with the weights being the density of the survival 
function beyond the censoring point. 
The fourth group consists of those patients who had no longitudinal measurements before their 
death times were censored. Let (𝑖 = 𝑟1 + 𝑟2 + 𝑟3 + 1, … , 𝑟1 + 𝑟2 + 𝑟3 + 𝑟4) denote the patients in 
group 4. Their log-likelihood contribution is given by the marginal likelihood of the censored 
survival times 𝑙4 = − ∑ exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ0(𝐶𝑖)
𝑁
𝑖=𝑁−𝑟4+1
.       
Notice that the baseline hazard λ0(𝑡)  and the cumulative baseline hazard Λ0(𝑡)  are 
unspecified nonparametric curves in the model. We borrow the idea from the profile likelihood 
approach (Murphy and van der Vaart 2000) where Λ0(𝑡) is profiled out by a step function, Λ̃0(𝑡), 
starting at zero and jumping at observed death times. Let 𝑑1, 𝑑2, … , 𝑑𝑀 denote the ascendingly 
ordered observed death times in the study. The 𝑚th jump at 𝑑𝑚 denoted by Λ̃0[𝑑𝑚] is given by 
Λ̃0[𝑑𝑚] =
1
∑ exp(𝐴𝑗𝛼𝐴 + ?̃?𝑗
𝑇𝛼𝑋)𝑗∈𝑅(𝑑𝑚)
,         𝑚 = 1, … , 𝑀, 
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where 𝑅(𝑑𝑚) denotes the at-risk group at death time 𝑑𝑚. The step function Λ̃0(𝑡) becomes the 
Breslow estimator of Λ0(𝑡)  when 𝛼𝐴  and 𝛼𝑋  are replaced by their MLE’s. This approach 
essentially puts the survival distribution masses on the observed death times. We substitute Λ̃0(𝑡) 
for Λ0(𝑡) in 𝑙1, 𝑙2, 𝑙3 and 𝑙4 and substitute  Λ̃0[𝐷𝑖] for 𝜆𝑜(𝐷𝑖) in 𝑙1 and 𝑙2 to obtain the new log-
likelihood function. Let 𝑙1
∗ , 𝑙2
∗  and 𝑙4
∗  denote the new log-likelihood functions corresponding to 
𝑙1, 𝑙2 and 𝑙4 after the substitution. It is straightforward to see that 
𝑙1
∗ = −0.5 ∑ [𝑛𝑖 log(2𝜋) + log|𝑉𝑖| + (𝑌𝑖 − 𝜇𝑖)
𝑇𝑉𝑖
−1(𝑌𝑖 − 𝜇𝑖)]
𝑟1
𝑖=1 + ∑ [log(Λ̃0[𝐷𝑖]) +
𝑟1
𝑖=1
𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋 − exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝐷𝑖)],                                                              
𝑙2
∗ = ∑ [log(Λ̃0[𝐷𝑖]) + 𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋 − exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝐷𝑖)]
𝑟1+𝑟2
𝑖=𝑟1+1
 
and  
𝑙4
∗ = − ∑ exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝐶𝑖)
𝑁
𝑖=𝑁−𝑟4+1
. 
The integral in 𝑙3 becomes Stieltjes integral (Terhorst 1986) after the substitution. Let 𝑙3
∗  denote 
the new log-likelihood corresponding to 𝑙3 after the substitution. It can be calculated as  
𝑙3
∗ = ∑ log ( ∑ 𝑓(𝑌𝑖|𝐷𝑖 = 𝑑𝑚)1(𝑑𝑚 > 𝐶𝑖)
𝑀
𝑚=1
𝑃𝑖𝑚)
𝑟1+𝑟2+𝑟3
𝑖=𝑟1+𝑟2+1
, 
where 1(𝑑𝑚 > 𝐶𝑖)  is an indicator function and 𝑃𝑖𝑚 = exp[𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋 − exp(𝐴𝑖𝛼𝐴 +
?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝑑𝑚)] Λ̃0[𝑑𝑚]. Notice that 𝑃𝑖𝑚 is the probability of the 𝑖th subject dying at 𝑑𝑚, and thus 
∑ 1(𝑑𝑚 > 𝐶𝑖)𝑃𝑖𝑚
𝑀
𝑚=1  should be the probability of surviving beyond 𝐶𝑖. However,  ∑ 1(𝑑𝑚 >
𝑀
𝑚=1
𝐶𝑖)𝑃𝑖𝑚  is actually not equal to the survival function 𝑃(𝐷𝑖 > 𝐶𝑖) = exp (− exp(𝐴𝑖𝛼𝐴 +
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?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝐶𝑖)) under the discretized survival distribution that put the masses on death times. This 
discrepancy could result in biased estimates. To correct this issue, we give a weight 𝑊𝑖 to 𝑃𝑖𝑚 so 
that ∑ 1(𝑑𝑚 > 𝐶𝑖)𝑊𝑖𝑃𝑖𝑚
𝑀
𝑚=1 = exp (− exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ̃0(𝐶𝑖)). The weight 𝑊𝑖 is then equal 
to 
exp(− exp(𝐴𝑖𝛼𝐴+?̃?𝑖
𝑇𝛼𝑋)Λ̃0(𝐶𝑖))
∑ 1(𝑑𝑚>𝐶𝑖)𝑃𝑖𝑚
𝑀
𝑚=1
. Let 𝑃𝑖𝑚
∗ = 𝑊𝑖𝑃𝑖𝑚. Thus, we have the weighted 𝑙3
∗  given by 
𝑤𝑙3
∗ = ∑ log ( ∑ 𝑓(𝑌𝑖|𝐷𝑖 = 𝑑𝑚)1(𝑑𝑚 > 𝐶𝑖)𝑃𝑖𝑚
∗
𝑀
𝑚=1
)
𝑟1+𝑟2+𝑟3
𝑖=𝑟1+𝑟2+1
. 
By having the weight 𝑊𝑖 in 𝑤𝑙3
∗ , our approach will generate exactly the same estimates as the 
partial likelihood approach for 𝛼𝐴 and 𝛼𝑋 when the longitudinal and survival data are independent. 
Notice that the weight 𝑊𝑖 should converge to 1 in probability because both the numerator and 
denominator of 𝑊𝑖  converges to exp (− exp(𝐴𝑖𝛼𝐴 + ?̃?𝑖
𝑇𝛼𝑋) Λ0(𝑡))  as the Breslow estimator 
converges to Λ0(𝑡) in probability (Zeng and Lin 2006). This means that the weight 𝑊𝑖 does not 
make a meaningful difference when there are enough number of subjects. 
The complete log-likelihood function can then be calculated as   
𝑙 = 𝑙1
∗ + 𝑙2
∗ + 𝑤𝑙3
∗ + 𝑙4
∗ . 
Parameter estimates are obtained by maximizing 𝑙 and variances are obtained from the Fisher 
information matrix. Point-wise CI can be constructed for the nonparametric curves 𝛽𝜇(𝑡
∗) and 
𝛽𝐴(𝑡
∗) based on the estimated variance matrix of the parameters. This estimation approach puts 
the survival distribution masses on the observed death times which induces another potential issue 
for our joint model: the log-likelihood contribution is not well defined for those subjects in group 
3 with death times censored beyond the last observed death time. To resolve this issue, we treat 
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the last observed time as a death time regardless of its actual censoring status. This approach was 
studied by Efron (1967) who showed that the Kaplan-Meier estimator remains consistent. We will 
study the sensitivity of this assumption for our joint modeling approach in the simulation study. 
3.3 Knots Selection 
Regression splines approach has the advantage of treating the model as if it were a parametric 
model once the knots were determined, but it requires appropriately selecting the number and 
position of knots. We adopt the popular method placing the knots at equally spaced sample 
quantiles of the data. There have been quite a lot of procedures developed in the literature to 
determine the optimal number of knots including cross-validation (Hastie and Tibshirani 1990), 
generalized cross-validation (GCV)  (Hastie and Tibshirani 1990, Nan et al. 2005), AIC and BIC. 
Generally, goodness of fit improves as a model becomes more complex (e.g., having more 
parameters). A good method for choosing knots is usually trying to select the number of knots 
such that it achieves the optimal balance between goodness of fit and model complexity. Goodness 
of fit can be measured by the sum of squared errors (SSE) or log-likelihood and the model 
complexity by the degrees of freedom (df) of the linear smoother or number of parameters that 
increase as the number of knots. For example, the GCV statistic is usually a ratio of an increasing 
function of (or weighted) SSE over a decreasing function of the df of the linear smoother, and thus, 
minimizing the GCV statistic results in a good balance between goodness of fit and model 
complexity. BIC and AIC are two other widely used model selection criteria that penalize the  
-2*log-likelihood (goodness of fit) by the number of parameters (model complexity). For the 
estimation approach outlined in this paper, the BIC or AIC criteria are the most natural choices 
since the log-likelihood function has a closed form expression. Because the AIC criterion places a 
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smaller penalty, relative to BIC, on model complexity, we have opted to use AIC to determine the 
optimal choice of knots. BIC gives similar results as shown in the simulation study. AIC statistic 
is defined by 
𝐴𝐼𝐶(𝑘1) = −2𝑙𝑜𝑔𝑙𝑖𝑘 + 2(#𝑝𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑠) = −2𝑙𝑜𝑔𝑙𝑖𝑘 + 2 [2𝑘1 + 𝑃 +
𝐿(𝐿 + 1)
2
+ 1 + 𝑄 + 1] 
The 𝑘1  minimizing the AIC statistic will be chosen as the optimal number of knots. It is 
straightforward to extend the procedure to the case with 𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) having different knots, 
but computational demand will increase as well on a higher order of magnitude. 
3.4 Quality-Adjusted Life Years (QALY) 
QALY is an important clinical endpoint and has been extensively discussed in the literature 
(Zhao and Tsiatis 1997, Cole et al. 1998, Cole et al. 2001, Cole et al. 2004, Wang and Zhao 2007, 
Jia and Lubetkin 2010). It is usually defined as a weighted life years in the form ∑ 𝑞𝑗𝑆𝑗
𝑘
𝑗=1  where 
𝑞1, … , 𝑞𝑘 are the discrete utility scores in each of the 𝑘 health states, and 𝑆1, … , 𝑆𝑘 are measures of 
life duration spent in each state observed in a study. The definition of utility scores may vary from 
study to study, but it is usually standardized into the range from 0 to 1 with 0 indicating worst 
possible QOL and 1 best possible QOL. When the utility score is considered as a continuous 
variable denoted by 𝑞(𝑡), QALY becomes the area under the longitudinal curve of the utility score, 
i.e., ∫ 𝑞(𝑡)𝑑𝑡
Δ⋀D
0
, where Δ⋀D = min (Δ, D), 𝐷 is the death time and Δ is the study duration or 
other time horizon for QALY. Under model (1) for the utility score and model (2) for the survival, 
the mean QALY can be calculated as 
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𝐸 [∫ 𝑞(𝑡)𝑑𝑡
Δ⋀D
0
] = 𝐸 [∫ 𝑞(𝑡)1(𝑡 ≤ 𝐷)𝑑𝑡
Δ
0
] = ∫ 𝐸[𝑞(𝑡)1(𝑡 ≤ 𝐷)]𝑑𝑡
Δ
0
= ∫ ( ∑ 𝐸[𝑞(𝑡)|𝑑𝑚]1(𝑡 ≤ 𝑑𝑚)
𝑀
𝑚=1
λ(𝑑𝑚)exp (−Λ(𝑑𝑚)))𝑑𝑡
Δ
0
= ∫ ∑ (𝒳𝑖(𝑑𝑚 − 𝑡)
𝑇𝛽)
𝑀
𝑚=1
1(𝑡 ≤ 𝑑𝑚)λ(𝑑𝑚) exp(−Λ(𝑑𝑚)) 𝑑𝑡
Δ
0
, 
where λ(. ) and Λ(. ) denote the hazard and cumulative hazard functions respectively. By plugging 
the mean value of the covariates into the above formula, Least-Squares-mean (Gianola 1982) type 
of estimates of the QALY can then be obtained for both treatment and control groups. In the 
application of our model to ENABLE III discussed later, the continuous standardized QOL 
(original score divided by the maximum of the scale 184) is defined as the utility.  
4. SIMULATION 
Finite sample properties of the estimators were studied through a simulation study where QOL, 
survival data, and two covariates (baseline QOL and sex) were randomly generated for an RCT 
with 250 subjects in each arm. We generated 1000 samples where baseline QOL (𝑞𝑜𝑙0) was 
generated with a Uniform distribution on (100, 150) and sex was generated with a Bernoulli 
distribution with the parameter 𝑝 = 0.5 . The models for the longitudinal QOL and survival 
outcome were as follows: 
𝑌𝑖(𝑡
∗) = 𝛽𝜇(𝑡
∗) + 𝐴𝑖𝛽𝐴(𝑡
∗) + 𝜓1𝑞𝑜𝑙0 + 𝜓2𝑠𝑒𝑥 + 𝑏𝑖 + 𝜖𝑖(𝑡
∗) 
and 𝜆𝑖(𝑡) = 𝜆𝑜(𝑡) exp(𝐴𝑖𝛼𝐴 + 𝛼1𝑞𝑜𝑙0 + 𝛼2𝑠𝑒𝑥), 
where 𝑏𝑖 is the random intercept with the scalar variance σ
2 = 36 and the residual 𝜖𝑖(𝑡
∗) has a 
scalar variance 𝜏2 = 16 . Here 𝛽𝜇(𝑡
∗) = 140 −
30
1+0.2𝑡
, 𝛽𝐴(𝑡
∗) = 30exp(−0.23𝑡 − 0.92),  𝜓1 =
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0.3,  𝜓2 = 1, 𝜆𝑜(𝑡) = exp (−2.5) and 𝛼𝐴 = −0.2, 𝛼1 = −0.005  and 𝛼2 = 0.2. The trajectory 
functions 𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) were chosen to have similar patterns to what was found in Li et al 
(2013). Repeated measurements of QOL were assumed to be taken at every half month until death. 
Censoring was assumed to be independent of the longitudinal data and survival, and was generated 
by 𝐺1(𝐺 < 𝑐) + 𝑐1(𝐺 ≥ 𝑐) where 𝐺 follows a Gamma distribution and 𝑐 is constant. To make 
the censoring rates similar to ENABLE III where there was 47.34% total censoring, 36.71% 
censored subjects having longitudinal QOL measurements (i.e., in group 3) and 4.35% censoring 
beyond the last observed death time, we set the shape and scale parameters of 𝐺 equal to 1.55 and 
14.3 respectively, 𝑐 = 33.65, and the first measurement of QOL was set to be collected at  𝑡 =
5.5. On average, there are 48.7% total censoring, 37.3% in group 3 and 5% censoring beyond the 
last observed death time in the simulated data sets. We selected the optimal number of knots for 
each sample within the range 𝑘1 ∈ [2, 11] using AIC. Results from the simulation showed that 
mean estimates of the natural cubic splines (dashed curves: Mean JM est.) were very close to the 
true function (the top panels of Figures 2 & 3). Results from a naïve approach were also presented 
in the figures for comparison which will be discussed later in this section. The pointwise coverage 
probabilities (CP) for 95% CI (dashed curves: JM 95% CP) were plotted in the bottom panels of 
Figures 2 & 3 with the mean coverage probabilities being 94.9% and 93.6% for 𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) 
respectively. The average number of knots was 5.72 when AIC was used and 5.03 for BIC. The 
estimation results looked similar when BIC was used. The Wald-type 95% CI of estimators for the 
regression coefficient parameters 𝜓1, 𝜓2, 𝛼𝐴, 𝛼1 and 𝛼2 (Table 1) had proper CP although there 
were some small biases for 𝜓1, 𝛼𝐴, 𝛼1 and a noticeable bias for 𝜓2. The mean of the standard error 
estimators correctly reflected the empirical variability of the parameter estimators.  
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Figure 2. Estimation results for 𝛽𝜇(𝑡
∗). The top panel shows the fit of the mean estiamted cuves 
from 1000 random samples along with the mean point-wise 95% CI for the joint modeling 
approach (JM) and the naïve approach. The bottom panel shows the point-wise 95% coverage 
probabilities for both methods and the ratio (JM/naive) of the width of the 95% CI.  
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Figure 3. Estimation results for 𝛽𝐴(𝑡
∗). The top panel shows the fit of the mean estimated cuves 
from 1000 random samples along with the mean point-wise 95% CI for the joint modeling 
approach (JM) and the naïve approach. The bottom panel shows the point-wise 95% coverage 
probabilities for both methods and the ratio (JM/naive) of the width of the 95% CI. 
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Table 1. Simulation results for the estimation of the parametric parameters. Bias is the mean of 
estimates minus the true values; Percent of Bias is the bias as a percentage of the true value. SE is 
the empirical standard error of the estimates; Mean SE is the mean of estimated standard errors; 
CP is the empirical coverage probability of the 95% CI for the parameters. Naïve Mean SE and 
Naïve CP are the counterparts from the naïve model. 
Longitudinal Model  
Parameter True Bias Percent 
of Bias 
(%) 
SE Mean.SE Naïve 
Mean.SE 
CP (%) Naïve 
CP (%) 
𝜓1 0.30 0.004 1.30 0.03 0.025 0.035 95.0 94.8 
𝜓2 1 -0.27 -27.29 0.68 0.71 1.00 94.9 94.8 
σ 6 0.21 3.53 0.26 0.26 -- 89.0 -- 
𝜏 4 <0.0001 <0.0001 0.04 0.04 -- 93.6 -- 
Survival Model 
𝛼𝐴 -0.2 -0.18 -10.82 0.12 0.12 0.13 94.4 95.0 
𝛼1 -0.005 -0.0001 2.13 0.004 0.004 0.004 94.3 93.7 
𝛼2 0.2 0.002 1.25 0.12 0.12 0.13 95.1 94.4 
 
We compared our joint modeling method with the naïve method (dotted curves in Figures 2 
& 3) where censored subjects were simply omitted for the longitudinal model (1) although the 
survival model (2) in the naïve analysis used all subjects. The naïve method generated less bias 
(results not shown), but our joint modeling method was much more efficient. The joint model 
approach achieved comparable CP with 26.1% narrower CI on average for 𝛽𝜇(𝑡
∗) and 34.4% 
narrower for 𝛽𝐴(𝑡
∗). In other words, the standard error (SE) estimates from the joint model were 
on average 26.1% and 34.4% smaller for 𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) respectively. The point-wise SE at 
large time points for 𝛽𝐴(𝑡
∗) could be over 60% smaller as indicated by the dash-dotted curve in 
the bottom panel of Figure 3. For the regression coefficient parameters in the model (Table 1), our 
approach achieves slightly better CP with 26.2% and 28.4% smaller SE estimates for 𝜓1 and 𝜓2 
respectively, and 2.4%, 3.1% and 3.1% smaller SE estimates for 𝛼𝐴 , 𝛼1  and 𝛼2  respectively. 
Therefore our joint modeling method was much more efficient than the naïve approach for 
estimating the longitudinal parameters. The main reason for the efficiency gain was that our 
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method used all the subjects in the modeling whereas the naïve method omitted the longitudinal 
QOL data from the censored subjects. Incorporating the association between the longitudinal QOL 
and survival outcomes also increased the efficiency reflected in the smaller SE estimates for the 
survival parameters. Even when the longitudinal and survival outcomes were independent, we still 
observed significant efficiency gain for estimating the longitudinal parameters (results not shown) 
although the survival parameter estimates were exactly the same as the naïve analysis. 
The overall censoring rate and the size of group 3 (defined in the Section 4 for estimation) in 
the ENABLE III study is on the high end relative to other palliative care studies including 
ENABLE II (Bakitas et al. 2009) and Temel et al. (2010). ENABLE II had 28.26% overall 
censoring with 18.94% in group 3. Simulation results (not shown) looked similar under the 
ENABLE II censoring rates and another intermediate censoring rates between ENABLE II and III 
(37% overall censoring and 27% in group 3). We also carried out a sensitivity study to examine 
the assumption that the last observed time is assumed to be a death time regardless of its actual 
censoring status. In both ENABLE II and III studies, the rates of censoring beyond the last 
observed death time (CBLD) happened to be the same and equal to 4.35%. It is unlikely to see a 
very high CBLD rate in palliative care studies since all patients have a relatively short prognosis. 
In the simulation settings described above, the average CBLD rates were set at 5%. Starting with 
the above setting with 48.7% total censoring, 37.3% in group 3 and 5% CBLD, we increased 
CBLD rate by lowering 𝑐, the upper bound of the censoring variable, to get 10%, 12.5% and 15% 
CBLD. We found that the biases increased with the CBLD rate for both parametric and 
nonparametric parameters and some CP fell below 90% for 12.5% and 15% CBLD although the 
CP for the parametric regression coefficients were relatively more stable. 
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5. APPLICATION 
We applied our model to the recently completed ENABLE III RCT (Bakitas et al. 2015) 
described in Section 2. In ENABLE III there were 103 subjects in the early treatment group and 
104 subjects in the delayed treatment group. Overall, the censoring rate was 47.34%; 36.71% 
censored subjects had longitudinal QOL measurements and 4.35% CBLD. The baseline QOL 
(𝑄𝑜𝐿0) and sex variables were adjusted in both the sub-models given by 
𝑌𝑖(𝑡
∗) = 𝛽𝜇(𝑡
∗) + 𝐴𝑖𝛽𝐴(𝑡
∗) + 𝜓1𝑄𝑜𝐿0 + 𝜓2sex + 𝑏𝑖 + 𝜖𝑖(𝑡
∗),                         (5) 
and 𝜆𝑖(𝑡) = 𝜆𝑜(𝑡) exp[𝐴𝑖𝛼𝐴 + 𝛼1𝑄𝑜𝐿0 + 𝛼2sex].                                (6) 
We used the same knots for the natural cubic splines estimating 𝛽𝜇(𝑡
∗) and 𝛽𝐴(𝑡
∗) in sub-model 
(5). Based on the AIC criterion, the optimal number of knots was 7. The fitted longitudinal 
trajectories using natural cubic splines in model (5) are shown in Figure 4 with 95% pointwise CI. 
Other parameters are given in Table 2. The slope of cumulative hazard function (Figure 5) was 
slightly larger until approximately 12 months for both groups indicating that the hazard of death 
was higher during that period. This explains the increasing pattern in Figure 1 since patients who 
survived beyond 12 months were likely less ill and presumably had better QOL. Only the baseline 
QOL (associated parameters are 𝜓1 and 𝛼1) was a significant predictor in both sub-models. The 
findings for the treatment effects were null at all time points which is consistent with the results 
presented in Bakitas et al. (2015). We also analyzed the data using naïve approach (results not 
shown) and the efficiency gain of our joint modeling approach for the longitudinal parameters was 
obvious. We also estimated the terminal trend using the piecewise linear joint modeling approach 
proposed in Li et al. (2013) and the results looked similar (Figure 4). Estimates and comparisons 
for QALY are presented in Table 3 for two time horizons: 33.5 months, the maximum observed 
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time, and 12 months, to compare earlier time horizons. The mean QALY and 95% CI are given in 
Table 3 where the delta method was used to obtain standard errors.   
Table 2. Estimates of model parameters 
Longitudinal Model Survival Model 
Parameter Estimate (SE) Parameter Estimate (SE) 
𝜓1 0.59 (0.05) 𝛼𝐴 -0.31 (0.19) 
𝜓2 2.58 (2.23) 𝛼1 -0.01 (0.005) 
σ 11.57 (0.99) 𝛼2 0.34 (0.20) 
𝜏 11.93 (0.41)   
 
 
Figure 4. Fitted longitudinal trajectories for the early and delayed treatment groups and the point-
wise 95% CI using the ENABLE III data. The piecewise linear curves (in grey) were obtained 
using the method in Li et al. (2013) 
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Figure 5. Fitted cumulative hazard functions at the mean values of the adjusted covariates for the 
early treatment group and delayed treatment groups using the ENABLE III data.  
 
Table 3. Estimated mean QALY with 95% CI in ENABLE III 
 Early treatment group Delayed treatment group 
Mean QALY in 
months 
33.5 months: 8.45 (8.04, 8.86) 
12 months: 4.96 (4.76, 5.16) 
33.5 months: 8.34 (7.94, 8.74) 
12 months: 4.90 (4.71, 5.08) 
 
6. DISCUSSION 
With the intention to establish a cutting-edge statistical approach for analyzing longitudinal 
QOL and survival data in palliative care research, we developed a novel semiparametric joint 
modeling method that directly estimates terminal trends of longitudinal QOL outcomes while 
incorporating censored survival information. The terminal trend estimation can help understand 
how patients may die in the (relatively) near future which is the key to caring well for patients and 
then plan appropriately (Murray et al. 2005). Our approach can be applied to a variety of 
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longitudinal outcomes and EOL research studies as well although the focus in this paper is 
longitudinal QOL outcome in palliative care studies. The nonparametric trajectory of the 
longitudinal QOL outcomes in the model makes the model highly flexible and not subject to model 
misspecification, and thus the model can be applied to other types of diseases as well as cancer. 
This approach appropriately accounts for the association between survival and longitudinal QOL 
outcomes, thus providing a more clinically meaningful estimate of the palliative care treatment 
effect. It accomplishes this by modeling the trajectories of the longitudinal QOL outcomes on a 
retrospective time scale. Dependence between censored death times (unknown time origins on a 
retrospective time scale) and the longitudinal QOL outcomes was appropriately modeled in the 
approach by constructing the joint likelihood function. One can also make inferences about QALY 
using this novel joint modeling approach. An R program to run the model is available upon request. 
Compared with the fully parametric approach developed in Li et al. (2013) for studies with 
cancer patients where they require pre-specification of breakpoints for the piecewise models, this 
semiparametric model has more flexible nonparametric mean structure of the longitudinal 
trajectory that is not subject to model misspecification. This advantage enables the semiparametric 
approach to model the longitudinal terminal trends for studies with non-cancer patients. Compared 
with other joint models briefly reviewed in the introduction, our approach directly models the 
longitudinal QOL outcomes prior to death on a retrospective time scale. As a result, interpretation 
of such an analysis in palliative care research is likely more reflective of the nature to study 
purposes. Our joint model is more efficient (generating smaller SE) than a naïve analysis that uses 
the decedents subsample for the longitudinal model and the full sample for the survival model as 
shown in the simulation study; although the efficiency gain for the survival model is small (3.1%).  
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A few possible extensions of our model are worth mentioning. Besides regression splines that 
were employed in the model, other nonparametric approaches (e.g., penalized splines, smoothing 
splines) could also be used and the estimation procedure will need to be modified accordingly. In 
the current approach, only the intercept and treatment effect are modeled with nonparametric 
functions in the longitudinal model. It can be easily extended to a more general case where the 
coefficients of other covariates are nonparametric functions as well. Another possible extension of 
the model is to add a shared random effect in the survival model (Liu, Wolfe, and Kalbfleisch 
2007) to account for another level of association between survival and the longitudinal QOL 
outcomes. To the best of our knowledge, there are limited developments for model diagnostic 
techniques for joint modeling in the literature. For shared parameter models, some informal 
diagnostic graphical procedures and multiple-imputation-based approaches to construct residuals 
and diagnostic plots can be found in the literature (Dobson and Henderson 2003, Rizopoulos, 
Verbeke, and Molenberghs 2010). Developments for model diagnostic tools under the terminal 
trend model may warrant further investigation.   
Comorbidities could be a potential issue because terminal trajectories are usually different for 
different types of illnesses. Patients with multiple disorders may have multiple trajectories running 
concurrently, with the more rapidly progressing trajectory typically dominating others (Murray et 
al. 2005). This is not uncommon in older patients with slowly progressive cancers and thus more 
complicated models may be needed for this case. Comorbidities could also be related to another 
issue as pointed out by Currow et al. (2012) that in palliative care RCTs, subjects often die as a 
direct result of disease progression or drop out for reasons unrelated to the treatment. Improper 
handling of those patients could make estimates systematically biased away from the true effect. 
They proposed a modified intent-to-treat analysis approach to address this issue by identifying 
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those who withdraw or die unrelated to the treatment and dropping them from the analysis. An 
alternative and better way to address this issue might be a joint modeling approach that 
appropriately models the survival and censoring distribution in terms of the treatment status to 
account for the informative dropouts. 
Longitudinal QOL data missing at random is an assumption that is oftentimes unverifiable in 
practice. In the ENABLE III RCT, longitudinal QOL measurements were missing with an 
intermittent pattern and the reasons include “too busy”, “lost interest in the study”, “too ill to 
respond” and “unknown”. Missing data as a result of being “too ill” might indicate that the missing 
longitudinal data was not missing at random; in such cases missing data could result in a bias in 
estimates. The semiparametric mixed effects model in the sub-model (1) for longitudinal QOL 
measurements should account well for the missing at random assumption since that is one of the 
advantages of mixed effects models. However, the results will be biased if data is not missing at 
random (or non-ignorable) and incorporating additional assumptions for the missing mechanism 
into the model could be helpful (Daniels and Hogan 2008). 
In this paper, the censoring distribution is assumed to be independent of the survival and the 
longitudinal outcomes. In general, this might not be the case although it is true in ENABLE III 
since survival status of all patients was identified at the end of ENABLE III trial, and hence there 
was only administrative censoring, a form of non-informative censoring. Under this assumption, 
efficiency is the only advantage of our joint modeling compared with the naïve analysis approach. 
However, if the censoring is informative, for example, censoring distribution depends on QOL, 
the naïve analysis will generate biased results because the decedent subsample might be a relatively 
less ill subsample than others. In this case, our joint modeling approach can be modified to generate 
 29 
 
unbiased results by incorporating the association of the censoring distribution with QOL in the 
model.    
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